| 05/08/2013 |
News: Biotest AG: Biotest AG: Annual general meeting approves increase of dividend
|
| 05/08/2013 |
News: Biotest AG: Biotest Group reports increase of EBIT
|
| 03/25/2013 |
News: Biotest AG: Biotest increases Profit before Tax by 28%
|
| 03/21/2013 |
News: Biotest AG: Biotest decides to move into biggest Phase IIb trial in company history
|
| 02/04/2013 |
News: Biotest AG: Biotest announces launch of BIVIGAM(TM)in the United States
|
| 01/21/2013 |
News: Biotest AG: Biotest AG with new sales and distribution activities in Russia and Greece
|
| 01/16/2013 |
News: Biotest AG: Biotest Announces Strategic Long-Term Manufacturing, Supply and License Agreement
|
| 01/09/2013 |
News: Biotest AG: Biotest AG's Supervisory Board extends the term of CEO Prof. Schulz and appoints Dr. Floß to the Board of Management
|
| 12/20/2012 |
News: Biotest AG: FDA Approves Biotest's BIVIGAM(TM), an Intravenous Immune Globulin (Human), 10% liquid
|
| 12/13/2012 |
News: Biotest AG: Biotest with new management team for research and regulatory affairs
|
| 12/11/2012 |
News: Biotest AG: Biotest AG signs strategically significant agreement to market human albumin in China
|
| 12/06/2012 |
News: Biotest AG: Biotest starts clinical development programme of human fibrinogen concentrate to treat serious, life-threatening bleeding
|
| 11/13/2012 |
News: Biotest AG: Biotest increases EBT by 26%
|
| 10/24/2012 |
News: Biotest AG: Biotest AG expands existing product portfolio with the marketing authorisation of Intratect 100 g/l (10%)
|
| 08/13/2012 |
News: Biotest AG: Biotest Group with double digit EBIT growth
|
| 08/07/2012 |
News: Biotest AG: Clinical Data on Efficacy and Safety of Bivigam(TM) accepted by FDA. Sales and profit guidance confirmed despite delays in US registration.
|
| 07/16/2012 |
News: Biotest AG: Biotest AG starts combination therapy study with BT-062 in multiple myeloma
|
| 05/10/2012 |
News: Biotest AG: Annual general meeting approves dividend
|
| 05/10/2012 |
News: Biotest AG: Biotest Group reports substantially higher EBIT
|
| 04/23/2012 |
News: Biotest consolidates its outstanding position in the hepatitis B hyperimmunoglobulin market with the marketing authorisation of Fovepta and with the initial sales of Hepatect(R) in Brazil
|
| 04/11/2012 |
News: Biotest AG: Biotest announces clinical trial data for its new investigational Intravenous Immunoglobulin (IVIG) product for the US market
|
| 03/22/2012 |
News: Biotest AG: Biotest reached an all-time high Profit after Tax
|
| 03/22/2012 |
News: Biotest AG: BT-062 demonstrates rapid and complete tumor eradication in preclinical studies
|
| 12/12/2011 |
News: Biotest AG: Clinical development of BT-062 in multiple myeloma expands into combination therapy
|
| 11/24/2011 |
News: Biotest AG: Tregalizumab (BT-061) shows efficacy in Chronic Plaque Psoriasis
|
| 11/10/2011 |
News: Biotest AG: Biotest: Significant Increase in Profit after Tax
|
| 08/11/2011 |
News: Biotest AG: First time Revenue and EBIT contribution by Biotherapeutics Segment; continuing difficult Plasma Protein Product Environment
|
| 08/01/2011 |
News: Biotest AG: Sale of Microbiological Monitoring business to Merck KGaA completed
|
| 06/22/2011 |
News: Biotest AG: Pentaglobin(R) shows high binding capacity against the current EHEC strain and its Shiga-like toxin 2
|
| 06/21/2011 |
News: Biotest AG: Abbott and Biotest Announce Global Agreement to Development and Commercialize Novel Antibody for Autoimmune Diseases
|
| 05/12/2011 |
News: Biotest AG: Biotest AG: Annual General Meeting approves dividend increase
|
| 05/10/2011 |
News: Biotest AG: Sales increase in the first quarter
|
| 03/22/2011 |
News: Biotest AG: Biotest: Monoclonal antibody BT-061 in combination with methotrexate demonstrates good efficacy in Rheumatoid Arthritis
|
| 03/22/2011 |
News: Biotest AG: Sales increase despite difficult market environment
|
| 01/27/2011 |
News: Biotest AG: Interim analysis of the Cytotect(R) Phase III trial in congenital cytomegalovirus (CMV) infection shows clear indication of efficacy
|
| 01/19/2011 |
News: Biotest AG: Biotest erwirbt Vertriebsgesellschaft in Brasilien
|
| 12/06/2010 |
News: Biotest AG: Clinical and pre-clinical data emphasise the potential of
|
| 11/17/2010 |
News: Biotest AG: Biotest: Pre-clinical studies demonstrate high efficacy of BT-062 in solid tumours
|
| 11/08/2010 |
News: Biotest AG: Biotest experiences sales growth
|
| 11/03/2010 |
News: Biotest AG: Biotest submits BivigamTM dossier for regulatory approval to US Food and Drug Administration
|
| 10/21/2010 |
News: Biotest AG: Monoclonal antibody BT-061 shows potential in the indication multiple sclerosis
|
| 08/12/2010 |
News: Biotest AG: Positive perspective despite difficult environment
|
| 08/11/2010 |
News: Biotest AG: Development of BT-062 makes further progress with start of a new clinical trial
|
| 08/10/2010 |
News: Biotest AG: Immunomodulatory antibody BT-061 shows competitive efficacy in the indication Rheumatoid Arthritis
|
| 08/10/2010 |
News: Biotest AG: BT-061 patent protection significantly expanded
|
| 07/14/2010 |
News: Biotest AG: Biotest increases sales despite greater financial pressure
|
| 05/11/2010 |
News: Biotest AG: Biotest shows sales growth in first quarter 2010 despite a difficult environment
|
| 05/06/2010 |
News: Biotest AG: Annual General Meeting 2010: Shareholders Approve Dividend of EUR 0.34 per Ordinary Share and EUR 0.40 per Preference Share
|
| 05/06/2010 |
News: Biotest AG: Biotest has recorded sales growth in first quarter 2010 despite a difficult environment
|
| 03/19/2010 |
News: Biotest AG: 2009 brings additional growth
|
| 03/17/2010 |
News: Biotest AG: Monoclonal antibody BT-061 shows efficacy in the indication psoriasis
|
| 01/06/2010 |
News: Biotest AG: Sale of Medical Diagnostics business to Bio-Rad completed
|
| 12/07/2009 |
News: Biotest AG: Immunoconjugate BT-062 shows first data of clinical efficacy
|
| 12/03/2009 |
News: Biotest AG: European Commission grants approval of Zutectra(R)
|
| 11/05/2009 |
News: Biotest AG: Biotest increases sales and earnings
|
| 10/23/2009 |
News: Biotest agrees to sell its Medical Diagnostics business to Bio-Rad Biotest AG:
|
| 10/20/2009 |
News: Biotest AG: Monoclonal antibody BT-061 shows efficacy in patients with rheumatoid arthritis
|
| 09/30/2009 |
News: Biotest AG: Clinical development of BT-063 started
|
| 09/28/2009 |
News: Biotest AG: Biotest AG receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for approval of Zutectra across the EU
|
| 08/12/2009 |
News: Biotest AG:Biotest remains successful
|
| 07/07/2009 |
News: Biotest AG: Further interim analyses confirm good clinical efficacy of the BT-061 monoclonal antibody.
|
| 05/15/2009 |
News: Biotest AG: Successful Start into 2009
|
| 05/07/2009 |
News: Biotest AG: Annual General Meeting: Shareholders Approve Dividend of EUR 0,30 per Ordinary Share and EUR 0,36 per Preference Share
|
| 04/07/2009 |
News: Biotest AG: Expansion of product offering and capacity
|
| 03/11/2009 |
News: Biotest AG: Successful Financial Year 2008
|
| 02/11/2009 |
News: Biotest AG: Biotest acquires further plasmapheresis centre
|
| 01/21/2009 |
News: Biotest AG: Cooperation secures additional plasma protein capacity
|
| 01/12/2009 |
News: Biotest AG: Expansion of plasma protein product range
|
| 12/15/2008 |
News: Biotest AG: Enhanced property rights for BT-062
|
| 12/10/2008 |
News: Biotest AG: Biotest expands plasma recovery capacities
|
| 12/10/2008 |
News: Biotest AG: European approval for Haemonine®
|
| 10/17/2008 |
News: Biotest AG: Biotest: proceeding successfully
|
| 09/22/2008 |
News: Biotest AG: Biotest: Promising start of clinical trial with BT062
|
| 09/08/2008 |
News: Biotest AG: Biotest: monoclonal antibody BT-061 shows clear indications of efficacy in the treatment of Psoriasis
|
| 08/18/2008 |
News: Biotest AG: Biotest: US approval increases potential of diagnostic business
|
| 08/07/2008 |
News: Biotest AG: Biotest strengthens self-sufficiency in Plasma Proteins
|
| 07/29/2008 |
News: Biotest AG: Biotest awarded patent protection in the USA
|
| 05/27/2008 |
News: Biotest AG: Payout of dividends increased, forecast improved
|
| 05/16/2008 |
News: Biotest AG: Successful start into the Year 2008
|
| 05/05/2008 |
News: Biotest AG: research into additional indications for monoclonal antibody BT-061
|
| 04/14/2008 |
News: Biotest AG: European approvals expand the market potential for plasma proteins
|
| 04/07/2008 |
News: Biotest AG: Biotest: Successful launch of plasma protein business in the USA
|
| 03/11/2008 |
News: Biotest AG: Biotest achieves major milestones in the development of biotherapeutics
|
| 02/22/2008 |
News: Biotest AG: 2007 a very successful year for Biotest
|
| 12/05/2007 |
News: Biotest AG:Biotest successfully completes acquisition of Nabi Biologics assets
|
| 11/09/2007 |
News: Biotest AG: Nabi shareholders approve sale of Biologics Business Unit to Biotest
|
| 11/05/2007 |
News: Biotest AG: Biotest: plasmapheresis centre in Dortmund opens
|
| 09/11/2007 |
News: Biotest AG:Biotest AG acquires plasma protein business unit from Nabi Biopharmaceuticals Corp.
|
| 08/10/2007 |
News: Biotest AG: Biotest remains on course for growth
|
| 08/01/2007 |
News: Biotest AG:Biotest and Abbott cooperate on a clinical trial for the expansion of the indication of Cytotect®
|
| 07/16/2007 |
News: Biotest AG: New clinical results increase market potential of Cytotect®
|
| 06/25/2007 |
News: Biotest AG: Biotest achieves further milestones in its monoclonal antibody development
|
| 06/15/2007 |
News: Biotest receives go-ahead to export culture media to the USA
|
| 05/03/2007 |
News: Biotest AG: successful start to 2007
|
| 03/13/2007 |
News: Biotest AG: Board of Management and Supervisory Board propose 82% dividend increase
|
| 02/14/2007 |
News: Biotest AG: 2006 financial year considerably better than expected
|
| 01/04/2007 |
News: Biotest AG: Orphan drug status for Cytotect® in the USA
|
| 12/21/2006 |
News: Biotest AG: Major milestones achieved in the development of monoclonal antibodies. – Commencement of clinical development of BT-061.
|
| 11/14/2006 |
News: Biotest AG: Biotest confirms sales and earnings target following good third quarter
|
| 11/02/2006 |
News: Biotest AG:Biotest obtained approval for improved Hepatect® product in six European countries
|
| 10/20/2006 |
News: Biotest AG: New Automated Assays for TANGO® Automated Blood Bank Systems under Food and Drug Administration Review
|
| 10/20/2006 |
News: Biotest AG: Biotest Diagnostics Corporation Announces Appointment of Vice President, Transfusion Diagnostics
|
| 10/20/2006 |
News: Biotest AG: Biotest announces important Milestone for Full Line of Manual Blood Bank Reagents
|
| 10/20/2006 |
News: Biotest AG: Olympus and Biotest redefine distribution relationship for Tango® systems
|
| 09/28/2006 |
News: Biotest AG: EMEA Committee in favour of Orphan Drug status for Cytotect®
|
| 08/14/2006 |
News: Biotest AG: Continuing growth
|
| 07/11/2006 |
News: Biotest secures exclusive rights to ImmunoGen’s world leading cytotoxic agent technologyest AG:
|
| 05/11/2006 |
News: Biotest AG: Stock option programme fails to achieve required majority
|
| 05/11/2006 |
News: Biotest AG:Good start to 2006 – a year of growth: Group sales up by 21%, overproportional growth recorded in earnings
|
| 03/22/2006 |
News: Biotest AG:“Focused research, global growth”: Biotest increases its market share worldwide and announces ambitious targets for 2006
|
| 03/22/2006 |
News: Biotest AG:Supervisory Board announces early extension of Dr. Michael Ramroth’s (CFO), contract by five years
|
| 02/17/2006 |
News: Biotest AG: Successful financial year 2005: Biotest increases sales, doubles the result and reduces financial liabilities
|
| 11/14/2005 |
Press release: Biotest continues excellent business growth in third quarter: Revenue +9%, EBIT +43%
|
| 10/31/2005 |
Press release: Successful capital increase for Biotest
|
| 10/18/2005 |
Press release: Biotest: World’s Largest Trade Conference is Kickoff for TANGO Marketing in the U.S.
|
| 10/13/2005 |
Press release: Biotest: Intratect® approved for nine European countries
|
| 10/11/2005 |
Press release: Biotest AG: Capital increase - Up to EUR 30 million for research and internationalisation
|
| 09/29/2005 |
Press release: Biotest: New study doubles the market potential of Cytotect®
|
| 08/05/2005 |
Press release: Biotest enjoys continued successful business growth - EBIT +27% in first six months 2005
|
| 07/28/2005 |
Press release: Biotest receives approval for TANGO reagents in US
|
| 07/01/2005 |
Press release: Capital increase: 10 million euro in new funds for antibody research
|
| 06/29/2005 |
Press release: Biotest wins TANGO tender
|
| 06/28/2005 |
Press release: Biotest AG and Boehringer Ingelheim Enter Into
|
| 05/20/2005 |
Press release: Biotest AG: Dr. Thorlef Spickschen new Chairman of the Supervisory Board
|
| 05/10/2005 |
Press release: Biotest : Q1 2005 continues positive trend
|
| 04/19/2005 |
Press release: Biotest : Successful fiscal year 2004 and first quarter of 2005
|
| 02/17/2005 |
Press release: Biotest AG and Lonza Enter into Manufacturing Agreement
|
| 01/26/2005 |
Press release: Biotest recorded revenues of EUR 218 million in 2004
|
| 01/21/2005 |
Press release: Biotest AG and AERES Biomedical Successfully Complete Engineering of the Antibody BT-062
|
| 11/22/2004 |
Press release: Biotest increases operating result by 70%
|
| 09/30/2004 |
Press release: STRATEC and BIOTEST conclude agreement on further development of TANGO
|
| 09/29/2004 |
Press release: Biotest launches new antibody product
|
| 07/08/2004 |
Press release: 2004 General Shareholders' Meeting – Biotest shareholders approve extensive capital measures
|
| 04/02/2004 |
Press release: Biotest generates operating profit in 2003
|
| 03/10/2004 |
Press release: Biotest sells its shareholding in SIFIN
|
| 02/23/2004 |
Press release: Biotest and Iranian Darou Pakhsh form joint venture
|
| 02/03/2004 |
Press release: Management changes at Biotest
|
| 01/26/2004 |
Press release: Biotest generates € 222 million turnover in 2003
|
| 10/01/2003 |
Press release: New chairman for the Biotest supervisory board
|
| 07/10/2003 |
Press release: Prof. Schulz appointed as Biotest`s new Chairman
|
| 07/01/2003 |
Press release: Biotest's new preparation against viral infections approved
|
| 06/16/2003 |
Press release: Successful Treatment of SARS Patients with Biotest Drug
|
| 06/10/2003 |
Press release: Biotest sells its shareholding in Envitec
|
| 03/05/2003 |
Press release: Biotest AG continues to market medical products
|
| 02/19/2003 |
Press release: New French transfusion guidelines will drive growth for Biotest's blood grouping analyser
|
| 01/29/2003 |
Press release: Biotest approved for Prime Standard segment
|
| 07/09/2002 |
Press release: Cooperation of Biotest and Olympus in the US and Canadian Market
|
| 05/22/2002 |
Press release: Biotest considers repurchase of shares
|
| 04/15/2002 |
Press release: Biotest AG achieved a 5.6 % growth in sales in 2001 and maintains dividend continuity
|
| 02/19/2002 |
Press release: Biotest announces stock option program
|
| 02/12/2002 |
Press release: Biotest Executive Dr. Reiner retired
|
| 01/21/2002 |
Press release: Biotest fulfills sales target
|
